[Neuroprotective effects of peptides.]

Abstract

Neurodegenerative diseases are a heterogeneous group of nervous system pathologies. They are found mainly in people of an older age group. The incidence of neurodegenerative diseases is continuously growing due to an increase in the average life expectancy of the population. At the moment, there are no effective and safe treatments for neurodegenerative diseases, which are most often diagnosed at the stage of decompensation, when therapy is ineffective and does not bring positive outcomes. Most of the currently used drugs act only symptomatically. The review provides analyzed data and information about the prospects of using peptide bioregulators as neuroprotectors with high physiological activity and low immunogenicity.

• Authors: E S Mironova, N S Linkova, I G Popovich, L S Kozina, V K Khavinson
• Journal: Advances in gerontology = Uspekhi gerontologii (Adv Gerontol) Vol. 33 Issue 2 Pg. 299-306 ( 2020) ISSN: 1561-9125 [Print] Russia (Federation)
• PMID: 32593244 (Publication Type: Journal Article, Review)

Chemical References

• Neuroprotective Agents
• Peptides

Topics

• Aged
• Humans
• Neurodegenerative Diseases (drug therapy, prevention & control)
• Neuroprotective Agents (pharmacology, therapeutic use)
• Peptides (pharmacology, therapeutic use)